A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is an open-label, single-arm Phase I/II clinical study to evaluate the efficacy and safety of Eque-cel Injection in patients with refractory immune-mediated necrotizing myopathy.
Epistemonikos ID: 8ae6873cc500d9d1fb0a448ebf00d4e2cdd0c2f7
First added on: Aug 08, 2026